# OXBRYTA

NDC: 72786-111
Generic name: Voxelotor
Labeler / Manufacturer: Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20211217

FDA application: NDA216157

## Active ingredients

- VOXELOTOR: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72786-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72786-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c557fac-29ec-483f-b691-8a935d4decc3